S

Sientra Inc
F:S0Z

Watchlist Manager
Sientra Inc
F:S0Z
Watchlist
Price: 1.302 EUR -3.41%
Market Cap: €206.4m

Sientra Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sientra Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
S
Sientra Inc
F:S0Z
Research & Development
-$11.8m
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Research & Development
-$62.2m
CAGR 3-Years
-9%
CAGR 5-Years
-15%
CAGR 10-Years
-3%
ICU Medical Inc
NASDAQ:ICUI
Research & Development
-$87.5m
CAGR 3-Years
2%
CAGR 5-Years
-15%
CAGR 10-Years
-19%
Align Technology Inc
NASDAQ:ALGN
Research & Development
-$369.9m
CAGR 3-Years
-7%
CAGR 5-Years
-16%
CAGR 10-Years
-20%
Lantheus Holdings Inc
NASDAQ:LNTH
Research & Development
-$177.3m
CAGR 3-Years
17%
CAGR 5-Years
-43%
CAGR 10-Years
-29%
Merit Medical Systems Inc
NASDAQ:MMSI
Research & Development
-$97.4m
CAGR 3-Years
-6%
CAGR 5-Years
-11%
CAGR 10-Years
-9%
No Stocks Found

Sientra Inc
Glance View

Market Cap
206.4m EUR
Industry
Health Care

Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. The company is headquartered in Santa Barbara, California and currently employs 319 full-time employees. The company went IPO on 2014-10-29. The firm's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. The firm sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. Implant Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The firm also offers breast tissue expanders for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The firm's brands also include Platinum20, Sientra Smooth, Sientra Teardrop, Allox, Allox2, Anatomical Controlled, BIOCORNEUM, Curve, Luxe, Softspan, Silishield and AuraG.

S0Z Intrinsic Value
Not Available

See Also

What is Sientra Inc's Research & Development?
Research & Development
-11.8m USD

Based on the financial report for Sep 30, 2023, Sientra Inc's Research & Development amounts to -11.8m USD.

What is Sientra Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-3%

Over the last year, the Research & Development growth was 11%. The average annual Research & Development growth rates for Sientra Inc have been -5% over the past three years , -3% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett